ヒトの血小板由来成長因子受容体βプロモーターで形成される主要なG-四重複体は,K+溶液で新しい断片鎖構造を採用する
Yuwei Chen1, Prashansa Agrawal, Robert V Brown
1Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, 1703 East Mabel Street, Tucson, Arizona 85721, USA.
Journal of the American Chemical Society
|August 8, 2012
まとめ
研究者らは,血小板由来成長因子受容体β (PDGFR-β) 遺伝子プロモーターに新しいDNAG四重複構造を特定した. 壊れたG鎖を持つこのユニークな構造は,PDGFR-β関連がんおよび線維性疾患の治療薬の開発に新しいターゲットを提供します.
科学分野:
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
- バイオケミストリー バイオケミストリー
背景:
- 血小板由来成長因子受容体β (PDGFR-β) の過剰発現は,がんや線維性疾患と関連している.
- PDGFR-βは,これらの疾患の治療標的である.
- PDGFR-βプロモーターのDNAG四重複体は,その転写を阻害する.
研究 の 目的:
- 人間のPDGFR-β遺伝子プロモーターにおける主要なG四重複構造を決定する.
- このG四重複の構造的特徴を理解するために.
- 薬物標的としての潜在能力を探求するためです.
主な方法:
- DNA G-四重複体の構造分析.
- プロモーターG-クアドルプレックス折り畳みの調査.
- G-四重複のモチーフのバイオ情報分析.
主要な成果:
- PDGFR-βプロモーターで新しいG-四重複構造が特定されました.
- このG四重複体は,壊れたG鎖と,主に平行鎖の分子内折りがある.
- それは3つの1核酸 (nt) のダブルチェーン反転ループと1つの横ループを含んでいます.
- 構造は,1ntループを持つ並列G四重複体の安定性を強調しています.
結論:
- 新しいPDGFR-βプロモーターのG-四重複構造は,小分子薬の潜在的な標的である.
- この構造をターゲットにすることで,PDGFR-β遺伝子発現を調節し,治療上の利点を得ることができます.
- 1ntループのG (i) NG (j) モチーフは,プロモーターG四重複体の進化的に選択された構造要素である可能性があります.
関連する概念動画
Restarting Stalled Replication Forks
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...


